The tools used to understand asthma better – share your experiences in a new survey

We have launched a new survey to understand how people with severe asthma feel about the tools used for asthma. These tools help doctors and nurses to check if a treatment is working for an individual patient.

This anonymous survey is part of a European project called 3TR. In this project we would like to understand patients’ views to choose the best tools for severe asthma and improve the care of patients across Europe.

Who can take part?

We would like to invite you to participate if:

  • You are 11 years of age or above and have severe asthma
  • You are a parent or carer of a person with severe asthma who is 6 years of age or above.

If you have severe asthma and are a parent or carer of someone with severe asthma, please complete the survey twice, once for yourself and once for your child or the person you care for.

The survey and news article are available in 14 languages: 

  • Bulgarian / Български
  • Czech / Čeština
  • Danish / Dansk 
  • Dutch / Nederlands
  • French / Français
  • English
  • German / Deutsch
  • Italian / italiano
  • Polish / polskim
  • Portuguese /Português
  • Russian / Русский
  • Spanish / Español
  • Swedish / Svenska
  • Turkish / Türkçe

Help us reach as many people as possible by sharing the survey link with anyone who may be interested in giving their views. The survey will take about 15 minutes to complete.

Who developed the survey?

This survey was developed by a group of patient representatives, healthcare professionals and researchers from the 3TR project, European Lung Foundation and European Federation of Allergy and Airways Diseases Patients Associations. 

The 3TR project aims to help us choose the right treatment for the right patient with severe asthma


If you have any questions, please email Kate Khaleva.

Thank you very much for helping us with this work.




This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 831434 (3TR). The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Disclaimer: Content of this publication reflects only the author’s view and the JU is not responsible for any use that may be made of the information it contains.